Agilent’s newly released GeneSpring GX 11.5 is a multiomics microarray and mass spectrometry based tool.

GeneGo has integrated Agilent Technologies’ GeneSpring Bioinformatics Solution with its pathway analysis technology, MetaCore.GeneSpring GX 11.5, released today, is a multiomics microarray and mass spectrometry based analysis suite that handles transcriptomics, genomics, metabolomics, and proteomics data in one application.

GeneSpring now includes a direct connection to MetaCore that allows users to upload expression data analyzed in GeneSpring for pathway analysis in MetaCore. “Our users have access to analysis and visualization tools within GeneSpring and the ability to combine statistical analysis in GeneSpring with MetaCore’s strengths in pathway analysis,” says Michael Janis, GeneSpring product manager at Agilent.

MetaCore 6.3 assists scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states, and toxicology. “MetaCore can concurrently visualize multiple types of data and will be able to take advantage of this new functionality in GeneSpring, which will be very helpful to our joint customers,” says Julie Bryant vp of business development at GeneGo.

Previous articleAriana and Bio-Rad Anchor HCV Diagnostic Collaborative
Next articleRoche Sublicenses EGFR IP from Genzyme to Develop Tarceva Companion Diagnostic